ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · Real-Time Price · USD
11.92
+1.38 (13.09%)
At close: Aug 13, 2025, 4:00 PM
11.92
0.00 (0.00%)
Pre-market: Aug 14, 2025, 8:57 AM EDT
ClearPoint Neuro Revenue
ClearPoint Neuro had revenue of $9.22M in the quarter ending June 30, 2025, with 17.27% growth. This brings the company's revenue in the last twelve months to $33.59M, up 19.68% year-over-year. In the year 2024, ClearPoint Neuro had annual revenue of $31.39M with 31.04% growth.
Revenue (ttm)
$33.59M
Revenue Growth
+19.68%
P/S Ratio
9.86
Revenue / Employee
$292,113
Employees
115
Market Cap
338.81M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 31.39M | 7.44M | 31.04% |
Dec 31, 2023 | 23.96M | 3.40M | 16.56% |
Dec 31, 2022 | 20.55M | 4.25M | 26.09% |
Dec 31, 2021 | 16.30M | 3.47M | 27.05% |
Dec 31, 2020 | 12.83M | 1.61M | 14.37% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
CLPT News
- 1 day ago - ClearPoint Neuro, Inc. (CLPT) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - ClearPoint Neuro Reports Second Quarter 2025 Results - Accesswire
- 9 days ago - ClearPoint Neuro Announces Progression of Key Partner Milestones throughout the Global Biologics and Drug Delivery Portfolio - Accesswire
- 21 days ago - ClearPoint Neuro to Announce Second Quarter 2025 Results August 12, 2025 - Accesswire
- 6 weeks ago - ClearPoint Neuro: Consumables Growth Is Promising - Seeking Alpha
- 3 months ago - I Missed The Quantum Rally - I Won't Miss The Next One - Seeking Alpha
- 3 months ago - ClearPoint Neuro, Inc. (CLPT) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - ClearPoint Neuro Reports First Quarter 2025 Results - Accesswire